How Computational Biology Speeds Drug Discovery, Development

A comprehensive look at how computational biology tools are helping emerging biopharmaceutical companies discover, design, and develop new molecules at record pace. Check out this discussion on two approaches to adopting computational technology – do-it-yourself and outsourcing – with two of the most innovative minds in the space, EVQLV’s Andrew Satz and Recursion President and COO Tina Larson. Whether you’re considering how AI and ML can increase drug discovery, design, and development efficiencies, dabbling in it already, or leading the charge, you won’t want to miss this conversation from the edge of what’s possible.

Available on-demand thanks to the support of Cytiva.